SURGICAL SITE INFECTIONS (by Naveed)

Embed Size (px)

Citation preview

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    1/39

    Click to edit Master subtitle style

    5/7/12

    WE L C O M E

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    2/39

    Click to edit Master subtitle style

    5/7/12

    SURGICAL SITEWOUND INFECTIONS

    BY:Rtr. DR. MAHAR NAVEED SARWARFCPS-II TRAINEE,WARD # 26,JPMC

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    3/39

    5/7/12

    IMPORTANT TERMS:Normal flora

    Various bacteria and fungi that are thepermanent residents of the certain body partswithout causing harm

    ColonizationPresence and multiplication of a new organism

    that is not the part of normal flora

    InfectionInvasion of normally sterile host tissue by a

    virulent microorganism OR

    Its invasion of organism into the body, followinga breach in the local or systemic host defenseleading to Systemic and local signs of

    inflammation

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    4/39

    5/7/12

    Lactobacilli

    StreptococciLactobacilli

    Enterobacteriac

    eae

    Aerobic+

    Anaerobic

    MicrobialPopulations

    NORMAL FLORA OF THE GITRACT

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    5/39

    5/7/12

    IMPORTANT TERMS:Bacterimia:

    Invasion of blood by viable bacteria withoutcausing any systemic upset

    Systemic inflammatory responsesyndrome SIRS:

    It is bodys inflammatory response to bothinfective and non-infective cause i.e.pancreatitis,trauma,vasculitis

    Defined by presence of any TWOof the

    following:Temperature >38.0C or 90/m R/R > 20/minWBC >12000 or

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    6/39

    5/7/12

    SURGICAL SITE

    INFECTIONS(SSIs)3rd most common nosocomial infection (after

    PNEUMONIA & UTI)

    Most common nosocomial infection amongsurgery patients

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    7/39

    5/7/12

    Criteria for defining SSIs

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    8/39

    5/7/12

    CRITERIA FOR DEFININGSSI

    Superficial surgical site infection (SSSI):

    Occurs within 30 days after operation

    Involves only skin and subcutaneous tissue

    with any of the following

    purulent discharge with or without laboratory confirmation;

    bacteria isolated from culture of wound;

    clinical signs (any one or more of following)

    pain/tenderness

    localized swelling

    Redness

    heat

    diagnosis of superficial SSI by attending surgeon.

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    9/39

    5/7/12

    Deep surgical site infections (DSSI)Occurs within 30 days after operation if no implant is

    placed or within 1 year if implant is placed Involves deep soft tissue e.g.: fascia and muscles

    with any of the following

    Purulent discharge from deep incision but not fromorgan/space component of the surgical site

    Deep incision dehisces spontaneously or deliberatelyopened by surgeon to evacuate pus

    Clinical signs (one or more of following) fever > 38 C localized pain tenderness

    Abscess/other evidence of deep infection Diagnosis by attending surgeon

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    10/39

    5/7/12

    Organ/ Space infection:

    Occurs within 30 days after operation if no implant is placed orwithin 1 year if implant is placed

    Involves the body cavities and its organs e.g.. abdominal abscessafter anastomotic leak

    And any of the following

    purulent discharge from the organ or a drain in space;

    organisms isolated from an aseptically obtained culture of fluid

    or tissues in organ/space; abscess or other evidence of infection involving organ/space

    found on :

    direct examination

    during reoperation or

    by histopathological or radiological examination

    diagnosis by attending surgeon..

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    11/39

    5/7/12

    FURTHER CLASSIFICATION

    SOURCE OF INFECTION

    a)Primary /endogenous:

    acquired from community or endogenous sourcesuch as following a perforated peptic ulcer)

    b)Secondary / exogenous(HAI):

    Infection arises following a complication that is notdirectly related to wound i.e. acquired from theater,

    ward

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    12/39

    5/7/12

    CONTNUED;TIME

    a) Early

    Infection presents within 30 days of procedure

    b) Intermediate

    Occurs between one and three months

    c) Late

    Presents more than three months after surgery

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    13/39

    5/7/12

    CONTNUED;

    SEVERITY a) Minor

    when there is discharge without Cellulitis ordeep tissue destruction

    With nil to mild systemic response

    b) MajorWhen there is spontaneous discharge of

    significant amount of pus orPartial or total dehiscence of the deep fascial

    layers of wound or

    if systemic illness is present.

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    14/39

    5/7/12

    WOUND ASSESMENT

    For surgical wound assessment severalscoring systems are employed especially

    ASEPSIS scoring

    Southampton wound assessment scale

    These enable surgical wound healing to be gradedaccording to specific criteria, thus providing moreobjective assessment of wound.

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    15/39

    5/7/12

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    16/39

    5/7/12

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    17/39

    5/7/12

    Class I wound (clean) Class I wounds are the simplesurgeries without violation ofthe hollow visceral structures ina non inflamed, atraumatic

    wound. e.g. inguinal herniarepair.

    No entry into GI, GU, Biliary, orrespiratory tract

    These wounds rarely becomeinfected

    Average infection rates are1.5%

    CLASSIFICATION OF SURGICAL WOUND

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    18/39

    5/7/12

    Class II Wound

    (Clean-Contaminated) Class II wounds involve

    controlled entry into a

    hollow visceral structure.e.g.cholecystectomy andelective colon resections

    Respiratory, GI, GU, orBiliary tract entered

    under controlledconditions

    Average infection ratesexpected are 7.5%

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    19/39

    5/7/12

    Class III Wounds

    (Contaminated)Traumatic wounds

    Breaks in steriletechnique

    Gross spillage from GItract

    Acute, nonpurulentinflammation

    Average anticipatedinfection rates are 15%

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    20/39

    5/7/12

    Class IV Wounds (Dirty) Old traumatic wounds

    Devitalized tissue

    Clinical infection

    present at the time ofoperation

    Perforated hollowviscus

    Average expectedinfection rates are 35%

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    21/39

    5/7/12

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    22/39

    5/7/12

    Microbiology

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    23/39

    5/7/12

    NATURAL DEFENSEMECHANISMS OF HUMAN

    BODYMechanical barriers:Intact epithelial surfaces

    Chemical barriers:

    Low gastric PHHumoral barriers:AntibodiesCompliment system

    OpsoninsCellular barriers:Phagocytic activity by cells like

    macrophages,neutrophils,NK cells

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    24/39

    5/7/12

    During surgery

    or trauma allof these

    mechanismsmay be

    compromised..!!!!!????

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    25/39

    5/7/12

    PATHOGENESIS FOR

    INFECTION

    VirulenceBacterial dose

    Impairedhost resistance

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    26/39

    5/7/12

    RISK FACTORS FOR SSIs

    Metabolic (Diabetes and Uremia)

    Malnutrition (Obesity and starvation )

    Nicotine use

    Steroid useRadiotherapy

    Chemotherapy

    Disseminated cancers and AIDS

    Poor perfusion (shock and ischemia)Foreign body material

    Poor surgical technique(increased dead tissue andhaematoma formation)

    Hospital stay

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    27/39

    5/7/12

    Nicotineuse

    Delays primary

    wound healingIncrease the risk

    of SSI

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    28/39

    5/7/12

    PREVENTION OF SSIs

    PROPHYLAXIS

    PREOPERATIVE CARE AND PREPARATION

    POSTOPERATIVE PRECAUTIONS

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    29/39

    5/7/12

    PROPHYLAXIS

    I/V administration of ABx within 30 minutes of induction

    Single dose of prophylactic ABx is equivalent totherapeutic ABx

    Repeat ABx 8 hourly and 16 hourly ifSurgery is prolonged (> 3 hours) Excessive blood loss in operative field(1500ml)

    Prosthesis placement

    Choice of ABx depends

    Its empirical cover against the expected pathogen Cost

    Local hospital policies (that are based on local trends ofresistance)

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    30/39

    5/7/12

    ABX

    Once the incision ismade,antibiotic delivery to thewound is impaired.Must give before incision!

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    31/39

    5/7/12

    TIME OF ADMINSTRATIION PERCENT SSIs

    Early (2-24 hours beforeincision)

    3.8%

    Preoperative (0-2 hours beforeincision)

    0.6%

    Perioperative (3 hours after

    surgery)

    1.4%

    Postoperative (more than 3hours after surgery)

    3.3%

    TIMINGS OF PROPHYLACTIC ANTIBIOTIC ADMINSTRATION AND SUBSEQUENTRATES OF SSIs

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    32/39

    5/7/12

    TYPE OF SURGERY ORGANISM ENCOUNTERD SUGGESTED

    PROPHYLACTIC REGIMENVascular Staph epidermidis

    Staph aureus

    Aerobes gram ve bacilli

    3 doses offlucloxacin,

    Vancomycin or rifampcin ifMRCNS/MRSA

    Orthopaedic Staph.A

    Staph.E

    1-3 doses of broadspectrum cephalosporin

    Oesophago-gastric Enterobacteriaceae

    Enterococci

    1-3 doses of 2ndgeneration cephalosporin+ metronidazole

    Biliary Enterobacteriaceae mainlyEcolab

    Enterococci

    1 dose of 2nd generationcephalosporin

    Small bowel Enterobacteriaceae

    Anaerobes (bacteroides)

    1-3 doses of 2ndgeneration cephalosporinwith or withoutmetronidazole

    Appendix/colorectal Enterobacteriaceae

    Anaerobes (bacteroides)

    1-3 doses of 2ndgeneration cephalosporin

    with metronidazole

    SUGGESTED PROPHYLACTIC REGIMENS FOR THE OPERATIONS AT RISK

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    33/39

    5/7/12

    PRE-OPERATIVE

    PREPARATIONShort hospital stayLowers the risk of MRSA/MRCNS and others HAIs

    Medical staff should always wash their hands in betweenpatients

    Strict aseptic care of intravenous lines; Isolation of infected cases.Preoperative shaving should be avoided, if necessary it

    should be undertaken just before the surgery Because minor skin injuries promote bacterial colonization and

    double the risk of SSIs)

    Hair clipping is best with lowest infection rates

    Attention to the theater technique & discipline Number of staff and their movement in & out of theater should

    be kept to minimum Proper ventilation of theater

    Proper instruments sterilization

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    34/39

    5/7/12

    CONTINUEDProper Scrubbing & skin preparation

    Thorough scrubbing including nails should be done beforefirst case in the morning

    Subsequent cases merely involve washing up to elbow (asrepeated scrubbing releases more organisms)

    Application of antiseptic over incision site decreases skinmicrobial colony counts

    Avoidance of preoperative hypothermia andsupplementation of O2 in recovery room have proved toreduce the risk of SSIs

    Drains: increase incisional SSI risk.

    Increase in the incidence of SSIs is also noted with the useof silk as a suture for skin closure

    If there is silk in the tissue the minimum number of organismneeded to start an infection is reduced logarthimatically

    (bailey & love 25th edition vol:I,page #35)

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    35/39

    5/7/12

    solutionsNAME PRESENTATION USES COMMENTS

    Chlorhexidine (hibiscrub)Alcoholic 0.5%

    Aqueous 4%

    Skin preparation

    Skin prep:, surgical scrubin dilute sol: in openwound

    Effective againstgram+ve

    Povione-iodine

    (betadine)

    Alcoholic 10%

    Aqueous 7.5%

    Skin preparation

    Skin prep:, surgical scrub

    in dilute sol: in openwound

    Safe ,fast acting, broadspectrum with some

    sporicidal activity

    Citrimide (savlon) aqueous Hand washing

    Instrument and surfacecleaning

    Pseudomonas may growin stored contaminatedsolutions

    Alcohols 70% ethyl, isopropyl Skin preparation should be reserved for

    the use as disinfectant

    hypochlorites Aqueouspreparations(eusol,milton,chloramine T)

    Instrument and surfacecleaning

    (debriding agent in openwound)

    Toxic to tissue

    Hexachlorophane Aqueous bisphenol Skin prep:

    hand washing

    Act against gram -ve

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    36/39

    5/7/12

    POSTOPERATIVE

    PRECAUTIONSPatients with established MRSA infectionsshould be

    Nursed in a separate room

    require specialist bacteriological advice about theantibiotic treatment needed.

    All attending staff (medical and nursing) should wearprotective clothing (plastic apron and gloves) that isdiscarded in a designated container immediately the

    patient is seen.This is followed by thorough disinfection of the hands.

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    37/39

    5/7/12

    TREATMENT OF SSIs

    Antibiotics are rarely used as the sole agentsto eradicate surgical infections;

    usually they constitute adjuvant treatment to

    surgery, e.g.excision of the infecting focus,

    drainage of abscesses,

    debridement,

    lavage of infected serous cavities.

    For established infections, the culture andsensitivity of the organisms to antibiotics isperformed

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    38/39

    5/7/12

    CONTINUED..

    Efflux of purulent material and pus

    removal of sutures and clips if suppuration is evident

    Fascia is intact:

    debridement Irrigated with N/S and

    packed to its base with saline-moistened gauze

    Fascia separated:

    drainage or reoperation

    healing by secondary intention

  • 8/2/2019 SURGICAL SITE INFECTIONS (by Naveed)

    39/39

    5/7/12

    n Discharge planning

    The intent of discharge planning:

    maintain integrity of the healing incision,

    educate the patient about the signs and symptoms

    of infection, advise the patient about whom to contact to report

    any problems.